Publications by authors named "Alice Morigi"

Claim this Profile
E
Efficacy and Safety of Frontline Single-Agent Rituximab in Extranodal Marginal Zone Lymphoma.
Camilla Mazzoni, Lisa Argnani, Beatrice Casadei, Alessandro Broccoli, Giulia Gabrielli, Alice Morigi

Eur J Haematol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endobronchial Presentation of Hodgkin Lymphoma Responding to Pembrolizumab: A Case Report.
Marianna Gentilini, Beatrice Casadei, Alice Morigi, Ginevra Lolli, Marco Ferrari

Chemotherapy· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged responses to brentuximab vedotin as last therapy in Hodgkin lymphoma failing autologous transplantation: A case series.
Alessandro Broccoli, Lisa Argnani, Paolo Elia Coppola, Marianna Gentilini, Gianmarco Bagnato, Alice Morigi

Tumori· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma: a real-life experience.
Vittorio Stefoni, Lisa Argnani, Matteo Carella, Beatrice Casadei, Alice Morigi

J Cancer Res Clin Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Droplet digital polymerase chain reaction for the assessment of disease burden in hairy cell leukemia.
Alessandro Broccoli, Carolina Terragna, Laura Nanni, Marina Martello, Silvia Armuzzi, Alice Morigi

Hematol Oncol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Efficacy and Safety of Ibrutinib in the Treatment of CLL Patients: A Real Life Experience.
Alessandro Broccoli, Lisa Argnani, Alice Morigi, Laura Nanni, Beatrice Casadei

J Clin Med· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The treatment of hairy cell leukemia with a focus on long lasting responses to cladribine: A 30-year experience.
Alessandro Broccoli, Lisa Argnani, Laura Nanni, Carolina Terragna, Elena Sabattini, Alice Morigi

Am J Hematol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment and outcomes of primary mediastinal B cell lymphoma: a three-decade monocentric experience with 151 patients.
Beatrice Casadei, Lisa Argnani, Alice Morigi, Ginevra Lolli, Alessandro Broccoli

Ann Hematol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real World Evidence of CAR T-Cell Therapies for the Treatment of Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: A Monocentric Experience.
Beatrice Casadei, Lisa Argnani, Serafina Guadagnuolo, Cinzia Pellegrini, Vittorio Stefoni, Alice Morigi

Cancers (Basel)· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravascular Large B-cell Lymphoma Successfully Treated with Autologous Transplantation.
Alice Morigi, Vittorio Stefoni, Lisa Argnani, Alessandro Broccoli, Pier Luigi Zinzani

Clin Lymphoma Myeloma Leuk· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful stem cell harvest and autologous transplantation in a patient with cold agglutinin syndrome and aggressive lymphoma.
Alice Morigi, Beatrice Casadei, Lisa Argnani, Vittorio Stefoni, Emanuela Sergio

Leuk Lymphoma· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential survival benefit for patients receiving autologous hematopoietic stem cell transplantation after checkpoint inhibitors for relapsed/refractory Hodgkin lymphoma: A real-life experience.
Beatrice Casadei, Lisa Argnani, Alice Morigi, Ginevra Lolli, Alessandro Broccoli

Hematol Oncol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of chemotherapy after anti-PD-1 blockade failure for relapsed and refractory Hodgkin lymphoma.
Beatrice Casadei, Lisa Argnani, Alice Morigi, Ginevra Lolli, Alessandro Broccoli

Cancer Med· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bendamustine-rituximab regimen in untreated indolent marginal zone lymphoma: experience on 65 patients.
Alice Morigi, Lisa Argnani, Ginevra Lolli, Alessandro Broccoli, Cinzia Pellegrini

Hematol Oncol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Granulomatous tattoo reaction in a nivolumab-treated patient.
Alessandro Pileri, Michela Starace, Miriam Leuzzi, Claudio Agostinelli, Elena Sabattini, Alice Morigi

G Ital Dermatol Venereol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y-ibritumomab tiuxetan in patients with extra-nodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) - The Zeno Study.
Ginevra Lolli, Lisa Argnani, Alessandro Broccoli, Miriam Marangon, Cinzia Pellegrini, Alice Morigi

Br J Haematol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spontaneous remission of follicular lymphoma.
Alice Morigi, Beatrice Casadei, Lisa Argnani, Michele Cavo, Pier Luigi Zinzani

Hematol Oncol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-1 blockade as bridge to allogeneic stem cell transplantation in relapsed/refractory Hodgkin lymphoma patients: a retrospective single center case series.
Beatrice Casadei, Alessandro Broccoli, Vittorio Stefoni, Cinzia Pellegrini, Miriam Marangon, Alice Morigi

Haematologica· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V600E-positive monomorphic epitheliotropic intestinal T-cell lymphoma complicating the course of hairy cell leukemia.
Alessandro Broccoli, Clara Bertuzzi, Michelangelo Fiorentino, Alice Morigi, Vittorio Stefoni

Onco Targets Ther· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case report of the long treatment experience of a Sézary syndrome responder patient: 16 years through all the systemic and innovative therapies.
Laura Nanni, Alice Morigi, Beatrice Casadei, Alessandro Broccoli, Vittorio Stefoni

Hematol Oncol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Berlin-Frankfurt-Münster protocol for the upfront treatment of aggressive lymphomas: The Bologna experience.
Miriam Marangon, Lorenzo Tonialini, Alice Morigi, Vittorio Stefoni, Alessandro Broccoli

Am J Hematol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Italian real life experience with ibrutinib: results of a large observational study on 77 relapsed/refractory mantle cell lymphoma.
Alessandro Broccoli, Beatrice Casadei, Alice Morigi, Federico Sottotetti, Manuel Gotti

Oncotarget· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The treatment of primary mediastinal large B-cell lymphoma: a two decades monocentric experience with 98 patients.
Alessandro Broccoli, Beatrice Casadei, Vittorio Stefoni, Cinzia Pellegrini, Federica Quirini, Alice Morigi

BMC Cancer· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Responders After Brentuximab Vedotin: Single-Center Experience on Relapsed and Refractory Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma Patients.
Letizia Gandolfi, Cinzia Pellegrini, Beatrice Casadei, Vittorio Stefoni, Alessandro Broccoli, Alice Morigi

Oncologist· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
9
90-yttrium-ibritumomab tiuxetan consolidation of fludarabine, mitoxantrone, rituximab in intermediate/high-risk follicular lymphoma: updated long-term results after a median follow-up of 7 years.
Beatrice Casadei, Cinzia Pellegrini, Alessandro Pulsoni, Giorgia Annechini, Amalia De Renzo, Alice Morigi

Cancer Med· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis